 |
市场调查报告书
商品编码
1741509
神经影像市场：按技术、应用、最终用户和地区划分Neuroimaging Market, By Technology, By Application, By End User, By Geography |
||||||
价格
简介目录
神经影像市场规模预计在 2025 年达到 422.8 亿美元，预计到 2032 年将达到 635.7 亿美元，2025 年至 2032 年的复合年增长率为 6%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025年的市场规模 | 422.8亿美元 |
| 效能数据 | 从2020年到2024年 | 预测期 | 2025年至2032年 |
| 预测期：2025-2032年复合年增长率： | 6.00% | 2032年价值预测 | 635.7亿美元 |
神经影像学是医疗图像的一个分支，它能够将大脑结构和功能视觉化。它为理解各种疾病和病症背后的神经过程和异常提供了宝贵的见解。这项技术彻底改变了神经科学领域，并大大促进了我们对人脑的理解。
市场动态：
神经影像市场受多种因素驱动。神经系统疾病的发生率不断上升，对精准诊断工具的需求也随之增加，进而推动了成像技术的普及。此外，磁振造影(MRI)、正子断层扫描 (PET) 和电脑断层扫描 (CT) 等影像技术的进步，显着提高了脑部影像的解析度和准确性。
然而，市场中也存在一些限制因素。神经影像设备的高昂成本以及相关的维护和运作成本限制了其普及，尤其是在开发中地区。某些显像模式的安全问题，例如电脑断层扫描中暴露于电离辐射，也对市场成长构成了挑战。
然而，神经影像市场蕴含着许多商机。预计将加大对研发 (R&D) 活动的投资，以开发功能性磁振造影(fMRI) 和扩散张量造影 (DTI) 等先进影像技术，将推动市场成长。个人化医疗的日益普及以及人工智慧 (AI) 在神经影像领域的整合，为市场扩张提供了新的途径。
本研究的主要特点
- 本报告对神经影像市场进行了详细分析，并提供了预测期 2025-2032（以 2024 年为基准年）的市场规模和年复合成长率(CAGR)。
- 它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
- 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
- 神经影像市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
- 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 神经影像市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
- 相关人员将透过用于分析神经影像市场的各种策略矩阵更轻鬆地做出决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规与趋势分析
- 市场动态
- 市场限制
- 市场机会
- 主要亮点
- 监管情景
- 近期动态
- 产品发布/核准
- PEST分析
- 波特分析
- 合併、收购和合作
第四章 神经影像市场－冠状病毒 (COVID-19) 大流行的影响
- COVID-19流行病学
- 供需侧分析
- 经济影响
5. 神经影像市场（依技术划分），2020 年至 2032 年
- 磁振造影（MRI）
- 电脑断层扫描（CT）
- 正子断层扫描（PET）
- 单光子发射电脑断层扫描（SPECT）
- 功能性磁振造影（fMRI）
- 扩散张量成像（DTI）
- 脑磁图（MEG）
- 脑电图（EEG）
- 其他的
6. 神经影像市场（依应用划分），2020 年至 2032 年
- 神经系统疾病
- 阿兹海默症
- 帕金森氏症
- 多发性硬化症
- 癫痫
- 中风
- 其他的
- 精神疾病
- 思觉失调症
- 躁郁症
- 忧郁症
- 焦虑症
- 其他的
- 创伤性脑损伤（TBI）
- 脑肿瘤
- 其他的
7. 神经影像市场（依最终使用者划分），2020 年至 2032 年
- 医院和诊所
- 诊断中心
- 研究机构
- 门诊手术中心
- 其他的
8. 2020 年至 2032 年神经影像市场（按地区）
- 北美洲
- 美国
- 加拿大
- 欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 南非
- 北非
- 中部非洲
第九章 竞争态势
- 公司简介
- GE Healthcare
- Siemens Healthineers
- Philips Healthcare
- Toshiba Medical Systems Corporation
- Hitachi Healthcare
- Canon Medical Systems Corporation
- Mindray Medical International Limited
- Esaote SpA
- NeuroLogica Corporation
- NeuroVive Pharmaceutical AG
- Brainlab AG
- Akili Interactive Labs Inc.
- Brainomix Ltd.
- Imaging Science International
- Mevis Medical Solutions
- NeuroVista
- Neusoft Medical Systems
- Positron Corporation
- Shimadzu Corporation
- Trifoil Imaging.
第 10 章 章节
- 参考
- 调查方法
- 关于出版商
简介目录
Product Code: CMI6384
Neuroimaging Market is estimated to be valued at USD 42.28 Bn in 2025 and is expected to reach USD 63.57 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 42.28 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.00% | 2032 Value Projection: | USD 63.57 Bn |
Neuroimaging is a branch of medical imaging that allows for the visualization of the structure and function of the brain. It provides valuable insights into the neurological processes and abnormalities that underline various diseases and disorders. This technology has revolutionized the field of neuroscience and has contributed significantly to understanding of the human brain.
Market Dynamics:
The neuroimaging market is driven by several factors. Growing prevalence of neurological disorders has increased the demand for accurate diagnostic tools, thus leading to the adoption of neuroimaging technologies. Moreover, the advancements in imaging technology, such as magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT), have significantly improved the resolution and accuracy of brain imaging.
However, the market also faces certain restraints. The high cost of neuroimaging equipment and the associated maintenance and operational costs limit its accessibility, especially in developing regions. Concerns regarding the safety of certain imaging modalities, such as ionizing radiation exposure in CT scans, pose challenges for market growth.
Nevertheless, the neuroimaging market presents several opportunities. The increasing investment in research and development (R&D) activities to develop advanced imaging techniques, such as functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI), is expected to drive market growth. Rising focus on personalized medicine and the integration of artificial intelligence (AI) in neuroimaging offer new avenues for market expansion.
Key features of the study:
- This report provides in-depth analysis of the neuroimaging market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the neuroimaging market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies. Key companies covered as a part of this study include General Electric Company, Siemens Healthineers AG, and Philips Healthcare, Toshiba Medical Systems Corporation, Hitachi Healthcare, Canon Medical Systems Corporation, Mindray Medical International Limited, Esaote SpA, NeuroLogica Corporation, NeuroVive Pharmaceutical AG, Brainlab AG, Akili Interactive Labs Inc., Brainomix Ltd., Imaging Science International, Mevis Medical Solutions, NeuroVista, Neusoft Medical Systems, Positron Corporation, Shimadzu Corporation, and Trifoil Imaging..
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The neuroimaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the neuroimaging market
Detailed Segmentation:
- Neuroimaging Market, By Technology:
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Functional Magnetic Resonance Imaging (fMRI)
- Diffusion Tensor Imaging (DTI)
- Magnetoencephalography (MEG)
- Electroencephalography (EEG)
- Others
- Neuroimaging Market, By Application:
- Neurological Disorders
- Alzheimers Disease
- Parkinsons Disease
- Multiple Sclerosis
- Epilepsy
- Stroke
- Others
- Psychiatric Disorders
- Schizophrenia
- Bipolar Disorder
- Depression
- Anxiety Disorders
- Others
- Traumatic Brain Injury (TBI)
- Brain Tumors
- Others
- Neuroimaging Market, By End User:
- Hospitals and Clinics
- Diagnostic Centers
- Research Institutes
- Ambulatory Surgical Centers
- Others
- Neuroimaging Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- GE Healthcare
- Siemens Healthineers
- Philips Healthcare
- Toshiba Medical Systems Corporation
- Hitachi Healthcare
- Canon Medical Systems Corporation
- Mindray Medical International Limited
- Esaote SpA
- NeuroLogica Corporation
- NeuroVive Pharmaceutical AG
- Brainlab AG
- Akili Interactive Labs Inc.
- Brainomix Ltd.
- Imaging Science International
- Mevis Medical Solutions
- NeuroVista
- Neusoft Medical Systems
- Positron Corporation
- Shimadzu Corporation
- Trifoil Imaging
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Market Restraints
- Market Opportunities
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTERs Analysis
- Mergers, Acquisitions, and Collaborations
4. Neuroimaging Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Neuroimaging Market, By Technology, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Magnetic Resonance Imaging (MRI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Computed Tomography (CT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Positron Emission Tomography (PET)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Single Photon Emission Computed Tomography (SPECT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Functional Magnetic Resonance Imaging (fMRI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Diffusion Tensor Imaging (DTI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Magnetoencephalography (MEG)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Electroencephalography (EEG)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Neuroimaging Market, By Application, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Alzheimers Disease
- Parkinsons Disease
- Multiple Sclerosis
- Epilepsy
- Stroke
- Others
- Psychiatric Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Schizophrenia
- Bipolar Disorder
- Depression
- Anxiety Disorders
- Others
- Traumatic Brain Injury (TBI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Brain Tumors
- Others
7. Neuroimaging Market, By End User, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2032
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
8. Neuroimaging Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 -2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Company Profile
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Philips Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Toshiba Medical Systems Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Hitachi Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Canon Medical Systems Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mindray Medical International Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Esaote SpA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- NeuroLogica Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- NeuroVive Pharmaceutical AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Brainlab AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Akili Interactive Labs Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Brainomix Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Imaging Science International
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mevis Medical Solutions
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- NeuroVista
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Neusoft Medical Systems
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Positron Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Shimadzu Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Trifoil Imaging.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- References
- Research Methodology
- About us
